Design Therapeutics
DSGN
DSGN
60 hedge funds and large institutions have $773M invested in Design Therapeutics in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
15% more funds holding
Funds holding: 52 → 60 (+8)
14.14% more ownership
Funds ownership: 50.85% → 64.98% (+14%)
Holders
60
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$19.3M | |
| 2 | +$16.7M | |
| 3 | +$6.46M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$6.21M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$3.59M |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$3.47M | |
| 3 | -$2.14M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$810K |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$219K |